ArticleTheranostics2024

Hypofractionated radiotherapy combined with lenalidomide improves systemic antitumor activity in mouse solid tumor models.

Kateryna Onyshchenko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.